<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cyanocobalamin (vitamin B12): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cyanocobalamin (vitamin B12): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Cyanocobalamin (vitamin B12): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9302" href="/d/html/9302.html" rel="external">see "Cyanocobalamin (vitamin B12): Drug information"</a> and <a class="drug drug_patient" data-topicid="11479" href="/d/html/11479.html" rel="external">see "Cyanocobalamin (vitamin B12): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F155136"><span class="drugH1">Brand Names: US</span>
<ul>
<li>B-12 Compliance Injection [DSC];</li>
<li>Dodex;</li>
<li>Nascobal;</li>
<li>Physicians EZ Use B-12;</li>
<li>True Vitamin B12 [OTC];</li>
<li>Vitamin Deficiency System-B12</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52866460"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Cobex [DSC];</li>
<li>Cyano Vit B12 [DSC];</li>
<li>JAMP-Cyanocobalamin [DSC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1057483"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Nutritional Supplement</span>;</li>
<li>
<span class="list-set-name">Vitamin, Water Soluble</span></li></ul></div>
<div class="block don drugH1Div" id="F53462414"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (AI):</b> Oral: 0.4 mcg/day (~0.05 mcg/kg/day) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-IOM.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-IOM.1'])">Ref</a></span>); <b>Note:</b> Neonates born to vegan mothers should be supplemented with the AI for vitamin B12 from birth; they may have low vitamin B12 stores at birth and, if breastfeeding, may only receive a small amount of the vitamin from the mother's milk (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11424546']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11424546'])">Ref</a></span>).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7550fb40-3093-4c4a-b6f9-a129f7bec73b">Anemia of prematurity</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anemia of prematurity:</b> Limited data available: IM: 100 mcg once monthly for 4 months with concomitant folic acid administration produced higher hemoglobin in 34 preterm neonates (GA &lt;36 weeks; birth weight &lt;1,800 g) when compared to placebo or folate monotherapy; all patients received vitamin E and iron supplementation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-7985636']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-7985636'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6ce27155-4827-4424-a41f-01b37972fc2a">Pernicious anemia; treatment of deficiency</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pernicious anemia; treatment of deficiency:</b> Limited data available: IM, SubQ: Initial: 1,000 mcg/day for 2 to 7 days based upon clinical response; followed by 100 mcg once weekly for 4 weeks and then maintenance dose: 100 mcg/month; <b>Note:</b> For severe anemia, a lower initial dose of 0.2 mcg/kg/dose for 2 days followed by the above regimen has been recommended due to potential hypokalemia observed during initial treatment of adults with severe anemia (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Orkin.1','lexi-content-ref-11148506']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Orkin.1','lexi-content-ref-11148506'])">Ref</a></span>); however, in more recent experience, while some adult patients may experience hypokalemia with initial treatment, this is unlikely to be clinically significant (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18606874']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18606874'])">Ref</a></span>). Some experts have recommended doses as low as 50 to 100 mcg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Orkin.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Orkin.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F155161"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="b719c3a8-a47b-4ec2-9e29-c4be331c41e5">Pernicious anemia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pernicious anemia:</b>
<b>Note: </b>Concurrent folic acid supplementation may also be needed.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Manufacturer's labeling: </i>Infants, Children, and Adolescents: IM, SubQ: 100 mcg once daily for 6 to 7 days; if improvement occurs, administer 100 mcg on alternate days for 7 doses, then every 3 to 4 days for 2 to 3 weeks; once hematologic values have returned to normal, maintenance dose: 100 mcg monthly.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Alternate dosing</i>: Limited data available: Infants, Children, and Adolescents: IM, SubQ: Initial: 1,000 mcg/day for 2 to 7 days based upon clinical response; followed by 100 mcg once weekly for 4 weeks and then maintenance dose: 100 mcg/month; for severe anemia, a lower initial dose of 0.2 mcg/kg/dose for 2 days followed by the above regimen has been recommended due to potential hypokalemia observed during initial treatment of adults with severe anemia (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Orkin.1','lexi-content-ref-11148506','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Orkin.1','lexi-content-ref-11148506','lexi-content-ref-23301732'])">Ref</a></span>); however, in more recent experience, while some adult patients may experience hypokalemia with initial treatment, this is unlikely to be clinically significant (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18606874']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18606874'])">Ref</a></span>). For infants and young children, some experts have recommended doses as low as 50 to 100 mcg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Orkin.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Orkin.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7b0de384-66ec-499b-8c2a-94bcbd318bfd">Vitamin B12 deficiency, severe</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin B12 deficiency, severe:</b> Limited data available; dosing regimens variable:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Dietary deficiency: </i>Infants (breastfed with vitamin B12 deficient mothers): IM: 250 to 1,000 mcg once daily for 1 to 2 weeks, followed by weekly dosing until patient recovers (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23301732'])">Ref</a></span>); patients with neurologic symptoms have been treated with doses of 1,000 mcg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22726312','lexi-content-ref-22711730']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22726312','lexi-content-ref-22711730'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Malabsorption: </i>Infants, Children, and Adolescents: IM: 250 to 1,000 mcg daily or every other day for 1 week, then weekly for 4 to 8 weeks, and then monthly for life; younger children should receive monthly doses of 100 mcg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20508991','lexi-content-ref-Kliegman.1','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20508991','lexi-content-ref-Kliegman.1','lexi-content-ref-23301732'])">Ref</a></span>). For infants and young children, some experts have recommended doses as low as 50 to 100 mcg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Orkin.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Orkin.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51090067"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Some formulations may also contain aluminum, which may accumulate in renal impairment.</p></div>
<div class="block dohp drugH1Div" id="F51090068"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F155139"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9302" href="/d/html/9302.html" rel="external">see "Cyanocobalamin (vitamin B12): Drug information"</a>)</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage guidance: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosage form information:</b> The cyanocobalamin content of over-the-counter products varies; it is generally higher in B-complex products (eg, 50 to 500 mcg) or products containing only vitamin B<sub>12</sub> (eg, 500 to 1,000 mcg) than in multivitamin products (eg, 5 to 25 mcg) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-NIH.1','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-NIH.1','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7918b6dd-7c8b-4f3d-bb04-0f97983c9efa">Aphthous stomatitis, simple, recurrent</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Aphthous stomatitis, simple, recurrent (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> May consider use regardless of serum vitamin B<sub>12</sub> levels (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19011392','lexi-content-ref-19124628']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19011392','lexi-content-ref-19124628'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral (sublingual):</b> 1,000 mcg once daily for 6 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19124628']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19124628'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IM:</b> 1,000 mcg once daily for 7 days, then 1,000 mcg once weekly for 1 month, then 1,000 mcg once monthly for 6 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19011392']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19011392'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f56c4882-0e25-49d6-aea6-2f835ab9e4ba">Drug toxicity reduction</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Drug toxicity reduction:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Pemetrexed:</i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IM:</b> 1,000 mcg every 9 weeks, beginning 1 to 3 weeks prior to pemetrexed treatment initiation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18506025','lexi-content-ref-12860938']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18506025','lexi-content-ref-12860938'])">Ref</a></span>); in patients without preexisting anemia, some data suggest that pemetrexed and cyanocobalamin may be started simultaneously to avoid delaying pemetrexed initiation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30825389']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30825389'])">Ref</a></span>). After the initial dose, may administer cyanocobalamin on the same day as pemetrexed; administer with oral folic acid supplementation.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Pralatrexate:</i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IM:</b> 1,000 mcg every 8 to 10 weeks, beginning within 10 weeks prior to pralatrexate treatment initiation; administer with oral folic acid supplementation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22394596']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22394596'])">Ref</a></span>). After the initial dose, may administer cyanocobalamin on the same day as pralatrexate.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="80ec2868-dab9-4252-8112-3c95cfa22874">Vitamin B<sub>12</sub> deficiency, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin B<sub>12</sub> deficiency, treatment:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Folic acid supplementation may also be required.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Severe/Symptomatic anemia or neurologic/neuropsychiatric findings:</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Initial therapy:</i></p>
<p style="text-indent:-2em;margin-left:8em;">
<b>IM, deep SUBQ:</b> 1,000 mcg 1 to 3 times/week or once daily for 1 week, then 1,000 mcg once weekly for 4 to 8 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-23301732'])">Ref</a></span>). Alternatively, if neurologic symptoms are present, may initiate 1,000 mcg every other day for up to 3 weeks or until no further improvement in signs or symptoms, then switch to 1,000 mcg once weekly for up to 12 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28925645','lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28925645','lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Maintenance therapy:</i></p>
<p style="text-indent:-2em;margin-left:8em;">
<b>Note:</b> Continue parenteral therapy until the deficiency has been corrected and signs and symptoms have resolved before switching to oral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">
<b>IM, deep SUBQ:</b> 1,000 mcg once monthly (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23301732'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">
<b>Oral, Sublingual:</b> 1,000 to 2,000 mcg once daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27602354','lexi-content-ref-Means.1','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27602354','lexi-content-ref-Means.1','lexi-content-ref-23301732'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Mild symptoms or asymptomatic:</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IM, deep SUBQ:</b> Initial: 1,000 mcg once weekly for 4 to 8 weeks; maintenance dose: 1,000 mcg once monthly (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-23301732'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral, Sublingual:</b> 1,000 to 2,000 mcg once daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27602354','lexi-content-ref-28925645','lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-12643357']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27602354','lexi-content-ref-28925645','lexi-content-ref-Means.1','lexi-content-ref-31917200','lexi-content-ref-12643357'])">Ref</a></span>).<b> Note:</b> In patients with impaired GI absorption (eg, pernicious anemia, bariatric surgery), or in whom adherence must be assured, parenteral administration may be required (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Intranasal (Nascobal):</b> Initial: 500 mcg (1 spray) in 1 nostril once weekly. Consider an alternative route if vitamin B<sub>12</sub> levels are persistently low after 1 month of treatment. <b>Note:</b> Some experts do not use intranasal formulations due to variable absorption (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Duration of therapy:</b> Continue indefinitely in patients with pernicious anemia or other irreversible cause of deficiency (eg, bariatric surgery); may discontinue therapy if a reversible cause of deficiency (eg, reduced dietary intake) has been addressed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28925645','lexi-content-ref-23301732','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28925645','lexi-content-ref-23301732','lexi-content-ref-manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="52cd6364-9fe5-4725-b937-b499b1c35337">Vitamin B<sub>12</sub> deficiency, prevention</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin B<sub>12</sub> deficiency, prevention:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For use in patients with risk factors for vitamin B<sub>12</sub> deficiency (eg, bariatric or gastric surgery, disorders of the stomach or terminal ileum, vegan or vegetarian diet) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral, Sublingual:</b> 350 to 1,000 mcg once daily; in patients with pernicious anemia, higher doses (eg, 1,000 to 2,000 mcg/day) are required (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27602354','lexi-content-ref-31917200']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27602354','lexi-content-ref-31917200'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IM, deep SUBQ:</b> 1,000 mcg once monthly <b>or</b> 1,000 to 3,000 mcg once every 6 to 12 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31917200','lexi-content-ref-23301732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31917200','lexi-content-ref-23301732'])">Ref</a></span>). <b>Note:</b> May be preferred in patients with impaired GI absorption (eg, pernicious anemia, bariatric surgery), or for whom adherence to oral therapy is challenging (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1','lexi-content-ref-31917200']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1','lexi-content-ref-31917200'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Intranasal (Nascobal):</b> 500 mcg (1 spray) in 1 nostril once weekly. Consider an alternative route if adequate vitamin B<sub>12</sub> levels cannot be maintained. <b>Note:</b> Some experts do not use intranasal formulations due to variable absorption (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Means.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Means.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Duration of therapy:</b> Continue indefinitely in patients with pernicious anemia or other irreversible cause of deficiency (eg, bariatric surgery); may discontinue therapy if a reversible cause of deficiency (eg, reduced dietary intake) has been addressed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28925645','lexi-content-ref-23301732','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28925645','lexi-content-ref-23301732','lexi-content-ref-manu.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991481"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Some formulations may also contain aluminum, which may accumulate in renal impairment.</p></div>
<div class="block doha drugH1Div" id="F50988827"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F155105"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Central nervous system: Headache (IM: 20%; intranasal: 4%)</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Infection (12% to 13%)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Asthenia (IM: 16%; intranasal: 4%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Central nervous system: Paresthesia (4%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Glossitis (nasal: 4%), nausea (4%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Rhinitis (4% to 8%)</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Cardiac failure, thrombosis (peripheral)</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Pruritus, skin rash (transient)</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Hypokalemia</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Diarrhea</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Polycythemia vera, thrombocythemia</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylactic shock (IM/SubQ)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Pulmonary edema</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Swelling</p></div>
<div class="block coi drugH1Div" id="F155120"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to cyanocobalamin (vitamin B<sub>12</sub>), cobalt, or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F155102"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• CNS effects: Vitamin B<sub>12</sub> deficiency for &gt;3 months results in irreversible degenerative CNS lesions; neurologic manifestations will not be prevented with folic acid unless vitamin B<sub>12</sub> is also given. Spinal cord degeneration might also occur when folic acid used as a substitute for vitamin B<sub>12</sub> in anemia prevention.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypokalemia: According to the manufacturer, treatment of severe vitamin B<sub>12</sub> megaloblastic anemia may result in severe hypokalemia, sometimes fatal, due to intracellular potassium shift upon anemia resolution; however, in more recent experience, while some patients may experience hypokalemia with initial treatment, this is unlikely to be clinically significant (Carmel 2008).</p>
<p style="text-indent:-2em;margin-left:4em;">• Thrombocytosis: Treatment of severe vitamin B<sub>12</sub> megaloblastic anemia may result in thrombocytosis.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Leber disease: Patients with Leber disease who received vitamin B<sub>12</sub> treatment have suffered from severe rapid optic atrophy. Use of cyanocobalamin in these patients is not recommended.</p>
<p style="text-indent:-2em;margin-left:4em;">• Megaloblastic anemia: Vitamin B<sub>12</sub> doses &gt;10 mcg daily may produce a hematologic response in patients with folate deficient megaloblastic anemia and mask previously unrecognized folate deficiency; vitamin B<sub>12</sub> is not a substitute for folic acid.</p>
<p style="text-indent:-2em;margin-left:4em;">• Polycythemia vera: Vitamin B<sub>12</sub> deficiency masks signs of polycythemia vera; vitamin B<sub>12</sub> administration may unmask this condition.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Intranasal administration: The effectiveness of intranasal cyanocobalamin in patients with allergic rhinitis, nasal congestion, and upper respiratory tract infections has not been determined. Defer treatment until symptoms have subsided.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• IV administration: Avoid intravenous route; anaphylactic shock has occurred.</p>
<p style="text-indent:-2em;margin-left:4em;">• Test dose: Intradermal test dose of vitamin B<sub>12</sub> is recommended for any patient suspected of cyanocobalamin hypersensitivity prior to administration.</p></div>
<div class="block dosfc drugH1Div" id="F57878669"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Not all available strengths or formulations may be represented in Dosage Forms.</p></div>
<div class="block foc drugH1Div" id="F155113"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">B-12 Compliance Injection: 1000 mcg/mL [DSC] [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Physicians EZ Use B-12: 1000 mcg/mL [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Vitamin Deficiency System-B12: 1000 mcg/mL [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Liquid, Sublingual: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 3000 mcg/mL (52 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lozenge, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 50 mcg (100 ea); 100 mcg (100 ea); 250 mcg (100 ea, 250 ea); 500 mcg (100 ea, 250 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dodex: 1000 mcg/mL (1 mL, 10 mL, 30 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1000 mcg/mL (1 mL, 10 mL, 30 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Nasal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nascobal: 500 mcg/0.1 mL (1 ea) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 500 mcg/0.1 mL (1 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">True Vitamin B12: 500 mcg, 1000 mcg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 100 mcg, 250 mcg, 500 mcg, 1000 mcg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1000 mcg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Extended Release, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1000 mcg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Sublingual, Sublingual [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2500 mcg</p></div>
<div class="block geq drugH1Div" id="F155098"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F155122"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Cyanocobalamin Injection)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1000 mcg/mL (per mL): $3.28 - $8.74</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Cyanocobalamin Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500 mcg/0.1 mL (per each): $191.51</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Dodex Injection)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1000 mcg/mL (per mL): $8.52</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Nascobal Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500 mcg/0.1 mL (per each): $212.79</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablet, controlled release</b> (Vitamin B-12 ER Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1000 mcg (per each): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Vitamin B-12 Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1000 mcg (per each): $0.04 - $0.22</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52866461"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cobex: 1000 mcg/mL ([DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 100 mcg/mL ([DSC]); 1000 mcg/mL (1 mL, 10 mL, 30 mL)</p></div>
<div class="block admp drugH1Div" id="F52612463"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Not generally recommended for treatment of severe vitamin B12 deficiency due to poor oral absorption (lack of intrinsic factor); oral administration may be used in less severe deficiencies and maintenance therapy; may be administered without regard to food</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: IM or deep SubQ are preferred routes of administration: Avoid IV administration due to a more rapid system elimination with resulting decreased utilization</p></div>
<div class="block adm drugH1Div" id="F155117"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Injection solution:</b> For IM or deep SUBQ administration only; do <b>not </b>administer IV.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Intranasal:</b> Nasal spray (Nascobal): Administer 1 hour before or 1 hour after ingestion of hot foods/liquids.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b> Some tablets are available for sublingual administration.</p>
<p style="text-indent:-2em;margin-left:4em;">Bariatric surgery: Tablet, extended release: Some institutions may have specific protocols that conflict with these recommendations; refer to institutional protocols as appropriate. Do not cut, crush, or chew. Switch to an IR tablet, chewable tablet, orally disintegrating or sublingual tablet, oral solution drops, or a nonoral formulation such as injection or nasal spray.</p></div>
<div class="block sts drugH1Div" id="F155131"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Injection: Store between 20°C and 25°C (68°F and 77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Protect from light.</p>
<p style="text-indent:-2em;margin-left:2em;">Intranasal spray: Store at 15°C to 30°C (59°F to 86°F); do not freeze. Protect from light.</p></div>
<div class="block usep drugH1Div" id="F53566264"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of pernicious anemia; vitamin B12 deficiency due to dietary deficiencies or malabsorption diseases; inadequate secretion of intrinsic factor, inadequate utilization of B12 (eg, during neoplastic treatment); increased B12 requirements due to pregnancy, thyrotoxicosis, hemorrhage, malignancy, liver or kidney disease (FDA approved in pediatric patients [age not specified] and adults)</p></div>
<div class="block cyt drugH1Div" id="F13299104"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F155106"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Chloramphenicol (Systemic): May diminish the therapeutic effect of Vitamin B12.<i> Risk C: Monitor therapy</i></p></div>
<div class="block foi drugH1Div" id="F155133"><span class="drugH1">Food Interactions</span>
<p style="text-indent:0em;display:inline">Heavy ethanol consumption &gt;2 weeks may impair vitamin B<sub>12</sub> absorption.</p></div>
<div class="block dic drugH1Div" id="F155123"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Strict vegetarian or vegan diets (eg, without eggs or dairy products) may result in vitamin B<sub>12</sub> deficiency (NIH 2021; manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (IOM 1998): </b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: 0.4 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: 0.5 mcg daily.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Recommended intake (IOM 1998): </b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: 0.9 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: 1.2 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years: 1.8 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">≥14 years: 2.4 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnancy: 2.6 mcg daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Lactation: 2.8 mcg daily.</p></div>
<div class="block pri drugH1Div" id="F14207663"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Water soluble vitamins cross the placenta. Absorption of vitamin B<sub>12</sub> may increase during pregnancy. Vitamin B<sub>12</sub> requirements may be increased in pregnant women compared to nonpregnant women. Serum concentrations of vitamin B<sub>12</sub> are higher in the neonate at birth than the mother (IOM 1998).</p></div>
<div class="block mopp drugH1Div" id="F53566252"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Vitamin B12, hemoglobin, hematocrit, erythrocyte and reticulocyte count, folate and iron levels should be obtained prior to treatment; vitamin B12 and peripheral blood counts should be monitored 1 month after beginning treatment, then every 3 to 6 months thereafter.</p>
<p style="text-indent:0em;margin-top:2em;">Evaluate serum methylmalonic acid (MMA) and total homocysteine levels at baseline (prior to supplementation) in untreated patients to confirm vitamin B12 deficiency (and extent of deficiency); repeat to confirm adequate supplementation (Stabler 2013).</p>
<p style="text-indent:0em;margin-top:2em;">Megaloblastic/pernicious anemia: In addition to normal hematological parameters, serum potassium and platelet counts should be monitored during therapy. <b>Note:</b> Some patients may develop hypokalemia during initial treatment; however, this is unlikely to be clinically significant (Carmel 2008).</p></div>
<div class="block rerp drugH1Div" id="F53565904"><span class="drugH1">Reference Range</span>
<p style="text-indent:0em;display:inline">Serum vitamin B12 levels: Normal: &gt;300 pg/mL (SI: &gt;221.2 pmol/L); vitamin B12 deficiency: &lt;200 pg/mL (SI: &lt;147.5 pmol/L) (200 to 300 pg/mL [SI: 147.5 to 221.2 pmol/L] borderline result, possible deficiency); megaloblastic anemia: &lt;100 pg/mL (SI: &lt;73.7 pmol/L).</p></div>
<div class="block pha drugH1Div" id="F155101"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Coenzyme for various metabolic functions, including fat and carbohydrate metabolism and protein synthesis, used in cell replication and hematopoiesis</p></div>
<div class="block phk drugH1Div" id="F155119"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action:</p>
<p style="text-indent:-2em;margin-left:4em;">Megaloblastic anemia: IM:</p>
<p style="text-indent:-2em;margin-left:6em;">Conversion of megaloblastic to normoblastic erythroid hyperplasia within bone marrow: 8 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Increased reticulocytes: 2 to 5 days,</p>
<p style="text-indent:-2em;margin-left:4em;">Complicated vitamin B<sub>12</sub> deficiency: IM, SUBQ: Resolution of:</p>
<p style="text-indent:-2em;margin-left:6em;">Psychiatric sequelae: 24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Thrombocytopenia: 10 days.</p>
<p style="text-indent:-2em;margin-left:6em;">Granulocytopenia: 2 weeks.</p>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Oral: Variable from the terminal ileum; requires the presence of calcium and gastric "intrinsic factor" to transfer the compound across the intestinal mucosa.</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Principally stored in the liver and bone marrow, also stored in the kidneys and adrenals.</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: Transcobalamins.</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Converted in tissues to active coenzymes, methylcobalamin and deoxyadenosylcobalamin; undergoes some enterohepatic recycling.</p>
<p style="text-indent:-2em;margin-left:2em;">Bioavailability: Intranasal (Nascobal): 6.1% (relative to IM); Oral: Pernicious anemia: 1.2%.</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak, serum: IM, SUBQ: 30 minutes to 2 hours; Intranasal: 1.25 ± 1.9 hours.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (50% to 98%, unchanged drug).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F155124"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Beto 12 | Betolvex | Campolon | Cobal | Cynovit | Nature made b12 vitamin | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Be positive b 12 | Lisoneurin b12 10.000 | Sl b12 | Veg 12 | Vegaone | Vitam doce</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Vitamin B12 Ankermann</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Blackmores vitamin b12 | Cytamen | Nanocelle b12 | Natures own activated methyl b12 | Sublingual B12 | Swisse Ultiboost Vitamin B12 | Ultra b12 | Vit b12 | Vita Science B12 | Vitamin b12 | Vitaqik liposomal vitamin b12 | Wagner vitamin b12 high strength</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Cynomin | Cynovit | Cytamen | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Neogenyl</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Vit b12 | Vitamine b12 tm</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Vitamin b12</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Amicored | Bedoze | Bedozil | Sidney oliveira vitamina b12 | Vitamin b-12 | Vitamina B 12 | Vitamina b12 | Vitaminas b12</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Betolvex | Vitamin b12 amino | Vitamin B12 Gattiker | Vitarubin</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Vitamina b12</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Qing gu an | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | Cianocobalamina | Iloban | Vitamina b12 | Vitamina b12 ecar</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Neurobene | Vitamin b12 | Vitamin B12 gamma</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Apovital Vitamin B12 | B12 | B12 ankermann | B12 Direct | B12 steigerwald | B12 Vicotrat | Cytobion | Sovita Vitamin B12 Opti | Vita aktiv b12 | Vita1 vitamin b12 | Vitamin b12 | Vitamin b12 compact | Vitamin B12 opti | Vitamin-b12-ratiopharm</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Cobal | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Rojamin | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | B12 Rotexmedica | Bethover b12 | Room vitamiin b12 | Vitamin b12 | Vitatabs b12</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Beto 12 | Betolvex | Deltavit b12 | Depofort | Naso cyanocobalamin | Rubivamine | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">B12 latino | Optovite b12</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">B12 vitamiini ratiopharm | B12 vitamin star | B12-vitamin | Betolvex</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Vitamine b12 aguettant | Vitamine B12 Bayer | Vitamine B12 Delagrange | Vitamine B12 Lavoisier | Vitamine b12 renaudin | Vitamine b12 roche</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Cobalin | Cytacon | Cytamen | Orobalin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Balamin | Bitamin | Cobalamin | Cobamin | Sunferbol | Uni Cynomin | Vitamin b12 | Vitamin b12 t p</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">B12 vitamin ankermann | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Arcored | Cobamin | Cyanovit | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Behepan | Cytacon | Cytamen</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Bedodeka | Bevitex</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Cyanocobalamine | Regen | Siocobin | Vib 12</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Bitamina | Dobetin | Reticulogen | Tonocian | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Cyanofix | Vitamin b12 | VitaminBt pharma vita b12 b12</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Fresmin | Hichion B12 | Redisol | Vitamin b12 kobayashi kako</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Cynamed | Cynozed</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Nascobal</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Betolvex | Ecavit B12 | Vitamin b-12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">B12 | Betolvex | Cobalex | Vitamin b 12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Cianocobalamin bp | Dobetin | Smart way vitamin b12 | Swanson b12 | Vitamin b complex | Vitamin b12 | Vitatabs b12</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Neogenyl</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Olimp labs b12 max | Vitamin b12 | Vitatabs b12</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Betamin 12 | Cyanocobalamine | Nature's bounty B 12 | Norvit | Prime B12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">B12 1000 sr | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | Behepan | Betolvex | Betolvidon | Nycoplus b12 vitamin | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">B12 | Bioceuticals b12 | Blackmores vitamin b12 | Country life vitamin b12 | Nanocelle b12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Aneurin b12 | B 12 | B12 ankermann | Gnc vitamin b-12 | Natures bounty b12 | Sundown naturals b12 | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Hyper b | Hyper b12 | Rubramin | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Bentamen | Cyanamin | Cyanocobalamine | Cynovit | Cytamen | Elkomin | Ephacobal | Hydromin | Newbal | Rexavit | Zolomine</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">B12 max | Cytobion | Energamma | Molekin b12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">B 12 | B-12 Dots | Calomist | Depinar | Dodex | Nature made b12 vitamin | Nature's bounty B 12 | Neurin | Neuro b 12 forte s | Neuro B12 forte | Neuroforte r | Poyamin | Rapid B-12 Energy | Vit B 12 | Vitamin b 12 | Vitamin b12 | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Bedoze | Betolvex | Cianocobalamina medinfar | Permadoze | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Cianocobalamina</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Cynovit</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | Vitamina b12 zentiva</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Betolvex | Cynovit | Ecavit B12</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Behepan | Betolvex | Betolvidon | Cykobemin | Nascobal | Novavita | Vitamin B 12 Recip</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">B 12 | Cobamine | Gnc vitamin b 12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Vitamin b12 | Vitamin B12 gamma</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">B12 ankermann | Bemego | Calvin | Cavin | Cyanomine | Cyavit | Cycon | Cycovit | Redisol | Sirepar | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Dodex</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Avicenna vitamin b12 | Beduzin | Cobalex | Cytamen | Dodex | Doppelherz aktiv vitamin b12 | Monovit B12 | Nevra b12 | Newita vitamin b12 | Nutrigen vitamin b12 | Tuesto vitamin b12 | Vit B 12 | Vitakobal | Vitatabs b12 | Vitawin vitami b12 | Voonka vitamin b12</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Cobaltomin | Coblamin-b12 | Cyanocobalamine | Hepacon B12 | Hichion B12 | Hicobalamin | Redisol | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">B12 20 mil | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Cianocobalamina | Cytacon | Dobetin | Vitamina b12</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Essentials vitamin b12 | Vitamin b12</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Parecon forte</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Parecon forte</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Aluminum.1">
<a name="Aluminum.1"></a>Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12390080">
<a name="12390080"></a>Andres E, Noel E, and Goichot B, “Metformin-Associated Vitamin B<sub>12</sub> Deficiency,” <i>Arch Intern Med</i>, 2002, 162(19):2251-2.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/12390080/pubmed" id="12390080" target="_blank">12390080</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20508991">
<a name="20508991"></a>Bjørke-Monsen AL and Ueland PM. Cobalamin status in children. <i>J Inherit Metab Dis</i>. 2011;34(1):111-119.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/20508991/pubmed" id="20508991" target="_blank">20508991</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control and Prevention (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>. Last accessed: May 4, 2017.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18606874">
<a name="18606874"></a>Carmel R. How I treat cobalamin (vitamin B12) deficiency. <i>Blood</i>. 2008;112(6):2214-2221. doi: 10.1182/blood-2008-03-040253.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/18606874/pubmed" id="18606874" target="_blank">18606874</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27602354">
<a name="27602354"></a>Chan CQ, Low LL, Lee KH. Oral vitamin B12 replacement for the treatment of pernicious anemia. <i>Front Med (Lausanne).</i> 2016;3:38. doi:10.3389/fmed.2016.00038<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/27602354/pubmed" id="27602354" target="_blank">27602354</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cyanocobalamin.1">
<a name="Cyanocobalamin.1"></a>Cyanocobalamin injection [prescribing information]. E. Windsor, NJ: AuroMedics Pharma LLC; May 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-HHS.1">
<a name="HHS.1"></a>Department Health and Human Services, Food Drug Administration. Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Federal Register</i>. 2000;65(17):4103-4111.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8856015">
<a name="8856015"></a>Goodman M, Chen XH, Daarwish D, “Are U.S. Lower Normal B<sub>12</sub> Limits Too Low?,” <i>J Am Geriatr Soc</i>, 1996, 44(10):1274-5.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/8856015/pubmed" id="8856015" target="_blank">8856015</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22726312">
<a name="22726312"></a>Guez S, Chiarelli G, Menni F, Salera S, Principi N, Esposito S. Severe vitamin B12 deficiency in an exclusively breastfed 5-month-old Italian infant born to a mother receiving multivitamin supplementation during pregnancy. <i>BMC Pediatr</i>. 2012;12:85.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/22726312/pubmed" id="22726312" target="_blank">22726312</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19011392">
<a name="19011392"></a>Gulcan E, Toker S, Hatipoğlu H, Gulcan A, Toker A. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. <i>Am J Med Sci.</i> 2008;336(5):379-382. doi:10.1097/MAJ.0b013e31816a05f2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/19011392/pubmed" id="19011392" target="_blank">19011392</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22394596">
<a name="22394596"></a>Horwitz SM, Kim YH, Foss F, et al. Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. <i>Blood</i>. 2012;119(18):4115-4122. doi:10.1182/blood-2011-11-390211<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/22394596/pubmed" id="22394596" target="_blank">22394596</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-IOM.1">
<a name="IOM.1"></a>IOM (Institute of Medicine), <i>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B</i><sub>6</sub><i>, Folate, Vitamin B</i><sub>12</sub><i>, Pantothenic Acid, Biotin and Choline</i>, Washington, DC: National Academy Press, 1998.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kaushansky.1">
<a name="Kaushansky.1"></a>Kaushansky K, Kipps TJ. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. <i>Goodman &amp; Gilman's: The Pharmacological Basis of Therapeutics, 12e</i> New York, NY: McGraw-Hill; . http://accessmedicine.mhmedical.com/content.aspx?bookid=1613&amp;sectionid=102161502. Accessed November 27, 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kliegman.1">
<a name="Kliegman.1"></a>Kliegman RM, Stanton BMD, St. Geme J, Schor NF, eds. <i>Nelson' s Textbook of Pediatrics</i>. 20th ed. Philadelphia, PA: Saunders Elsevier; 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24327038">
<a name="24327038"></a>Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. <i>JAMA</i>. 2013;310(22):2435-2442.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/24327038/pubmed" id="24327038" target="_blank">24327038</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12086562">
<a name="12086562"></a>Lane LA and Rojas-Fernandez C, “Treatment of Vitamin B<sub>12</sub>-Deficiency Anemia: Oral versus Parenteral Therapy,” <i>Ann Pharmacother</i>, 2002, 36(7-8):1268-72.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/12086562/pubmed" id="12086562" target="_blank">12086562</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28925645">
<a name="28925645"></a>Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. <i>Am Fam Physician.</i> 2017;96(6):384-389.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/28925645/pubmed" id="28925645" target="_blank">28925645</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21671542">
<a name="21671542"></a>Langan RC, Zawistoski KJ, “Update on Vitamin B12 Deficiency,” <i>Am Fam Physician</i>, 2011, 83(12):1425-30.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/21671542/pubmed" id="21671542" target="_blank">21671542</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3374544">
<a name="3374544"></a>Lindenbaum J, Healton EB, Savage DG, et al, “Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis,” <i>N Engl J Med</i>, 1988, 318(26):1720-8.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/3374544/pubmed" id="3374544" target="_blank">3374544</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11424546">
<a name="11424546"></a>Mangels AR and Messina V, "Considerations in Planning Vegan Diets: Infants," <i>J Am Diet Assoc</i>, 2001, 101(6):670-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/11424546/pubmed" id="11424546" target="_blank">11424546</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Means.1">
<a name="Means.1"></a>Means RT, Fairfield KM. Treatment of vitamin B12 and folate deficiencies. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="https://www.uptodate.com" target="_blank">https://www.uptodate.com</a>. Accessed January 12, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31917200">
<a name="31917200"></a>Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic &amp; Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. <i>Surg Obes Relat Dis.</i> 2020;16(2):175-247. doi:10.1016/j.soard.2019.10.025<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/31917200/pubmed" id="31917200" target="_blank">31917200</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nascobal.1">
<a name="Nascobal.1"></a>Nascobal (cyanocobalamin) [prescribing information]. Chestnut Ridge, NY: Par Pharmaceutical Companies; November 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health (NIH). Vitamin B12 - health professional. <a href="https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/</a>. Updated April 6, 2021. Accessed August 30, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nelson.1">
<a name="Nelson.1"></a>Nelson Textbook of Pediatrics, 17th ed, Behrman RE, Kliegman RM, and Jenson HB, eds, Philadelphia, PA: WB Saunders Co, 2004.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12643357">
<a name="12643357"></a>Oh R, Brown DL. Vitamin B<sub>12</sub> deficiency. <i>Am Fam Physician.</i> 2003;67(5):979-986.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/12643357/pubmed" id="12643357" target="_blank">12643357</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2930611">
<a name="2930611"></a>Olszewski AJ, Szostak WB, Bialkowska M, et al, “Reduction of Plasma Lipid and Homocysteine Levels by Pyridoxine, Folate, Cobalamin, Choline, Riboflavin, and Troxerutin in Atherosclerosis,” <i>Atherosclerosis</i>, 1989, 75(1):1-6.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/2930611/pubmed" id="2930611" target="_blank">2930611</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Orkin.1">
<a name="Orkin.1"></a>Orkin S, Nathan D, Ginsbirg, D, et al, eds. <i>Nathan and Oski's Hematology and Oncology of Infancy and Childhood</i>. 8th ed. Saunders; 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28392254">
<a name="28392254"></a>Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. <i>Surg Obes Relat Dis</i>. 2017;13(5):727-741.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/28392254/pubmed" id="28392254" target="_blank">28392254</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11148506">
<a name="11148506"></a>Rasmussen SA, Fernhoff PM, and Scanlon KS, “Vitamin B<sub>12</sub> Deficiency in Children and Adolescents,” <i>J Pediatr</i>, 2001, 138(1):10-17.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/11148506/pubmed" id="11148506" target="_blank">11148506</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1627675">
<a name="1627675"></a>Regland B, Gottfries CG, and Lindstedt G, “Dementia Patients With Low Serum Cobalamin Concentration: Relationship to Atrophic Gastritis,” <i>Aging (Milano)</i>, 1992, 4(1):35-41.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/1627675/pubmed" id="1627675" target="_blank">1627675</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22711730">
<a name="22711730"></a>Roumeliotis N, Dix D, Lipson A. Vitamin B(12) deficiency in infants secondary to maternal causes. <i>CMAJ</i>. 2012;184(14):1593-1598.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/22711730/pubmed" id="22711730" target="_blank">22711730</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18506025">
<a name="18506025"></a>Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. <i>J Clin Oncol</i>. 2008;26(21):3543-3551. doi:10.1200/JCO.2007.15.0375<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/18506025/pubmed" id="18506025" target="_blank">18506025</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2693230">
<a name="2693230"></a>Schjonsby H, “Vitamin B<sub>12</sub> Absorption and Malabsorption,” <i>Gut</i>, 1989, 30(12):1986-91.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/2693230/pubmed" id="2693230" target="_blank">2693230</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12190367">
<a name="12190367"></a>Schnyder G, Roffi M, Flammer Y, et al, “Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial,” <i>JAMA</i>, 2002, 288(8):973-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/12190367/pubmed" id="12190367" target="_blank">12190367</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7832937">
<a name="7832937"></a>Silbergleit R and Lee DC, “Bowel Obstruction and Radiopaque Vitamin B<sub>12</sub> “Pseudobezoar”,” <i>Am J Emerg Med</i>, 1995, 13(1):112-3.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/7832937/pubmed" id="7832937" target="_blank">7832937</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30825389">
<a name="30825389"></a>Singh N, Baldi M, Kaur J, et al. Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: the PEMVITASTART randomized trial. <i>Cancer</i>. 2019;125(13):2203-2212. doi:10.1002/cncr.32028<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/30825389/pubmed" id="30825389" target="_blank">30825389</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19116332">
<a name="19116332"></a>Smith AD, Refsum H. Vitamin B-12 and cognition in the elderly. <i>Am J Clin Nutr</i>. 2009;89(2):707S-711S.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/19116332/pubmed" id="19116332" target="_blank">19116332</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23301732">
<a name="23301732"></a>Stabler SP. Clinical practice. Vitamin B12 deficiency. <i>N Engl J Med</i>. 2013;368(2):149-160. doi:10.1056/NEJMcp1113996<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/23301732/pubmed" id="23301732" target="_blank">23301732</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12860938">
<a name="12860938"></a>Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. <i>J Clin Oncol</i>. 2003;21(14):2636-2644. doi:10.1200/JCO.2003.11.136<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/12860938/pubmed" id="12860938" target="_blank">12860938</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19124628">
<a name="19124628"></a>Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B<sub>12</sub> in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial.<i> J Am Board Fam Med.</i> 2009;22(1):9-16. doi:10.3122/jabfm.2009.01.080113<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/19124628/pubmed" id="19124628" target="_blank">19124628</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7985636">
<a name="7985636"></a>Worthington-White DA, Behnke M, and Gross S, "Premature Infants Require Additional Folate and Vitamin B<sub>12</sub> to Reduce the Severity of the Anemia of Prematurity," <i>Am J Clin Nutr</i>, 1994, 60(6):930-5.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-pediatric-drug-information/abstract-text/7985636/pubmed" id="7985636" target="_blank">7985636</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 13187 Version 447.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
